Література Підвищення частоти клінічного та гістологічного раку простати з віком: вікові зміни місцевого імунного нагляду

рак простата злокачественный заболевание.

• 1. Pienta, K.J.: Etiology, epidemiology, and prevention of carcinoma of the prostate. In: Campbell’s Urology, 7th ed. Edited by P.C. Walsh, A.B. Retik, E.D. Vaughan, Jr. and A.J. Wein. Philadelphia: W.B. Saunders Co., vol. 2, sect. Xl, chapt. 80, pp. 2489−2497, 1998.
• 2. Bissada, N. K: Prostate cancer: an overview. J S C Med Assoc, 96:52, 2000.
• 3. Huang, H. and Tindall, D.J.: The role of the androgen receptor in prostate cancer. Crit Rev Eukaryot Gene Expr, 12: 193, 2002.
• 4. Lee P., Lee, H., Guo, S., Unterman, T.G., Jenster, G. and Bai, W.: AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FK11R. Mol Cell Biol, 23: 104, 2003.
• 5. Makridakis, N.M. and Reichardt, J.K. V.: Molecular epidemiology of androgen-metabolic loci in prostate cancer: predisposition and progression. J Urol, suppl., 171: S25, 2004.
• 6. Thomas, L.: Discussion of cellular and humoral aspects of the hypersensitive states. In: Cellular and Humoral Aspects of the Hypersensitive States. Edited by H.S. Lawrence. New-York: Hoeber-Harper, pp. 529−532, 1959.
• 7. Burnet, F.M.: Immunological aspects of malignant disease. Lancet, 1: 1171, 1967.
• 8. Markiewicz, M.A. and Gajewski, T.F.: The immune system as anti-turnor sentinel: molecular requirements for an anti-tumor immune response. Crit Rev Oncog, 10: 247, 1999.
• 9. Kumar, V., Cotran, R.S. and Robbins, S.L.: Neoplasia. In: Basic Pathology, 6th ed. Philadelphia: W. B. Saunders Co., pp. 167−169, 1997.
• 10. Greenberg, P.D.: Mechanisms of tumor immunology. In: Medical Immunology, 10th ed. Edited by J. Foltin, 1. Nogueira and B. Holton. Philadelphia: McGraw-Hill, Inc., pp. 568−577, 2001.
• 11. Smyth, M.J., Godfrey, D. 1. and Trapani, J.A.: A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol, 2: 293, 2001.
• 12. Berczi, L, Bertok, L. and Chow, D.A.: Natural immunity and neuroimmune host defense. Ann N Y Acad Sci, 917: 248, 2000.
• 13. Whiteside, T.L. and Herberman, R.B.: The role of natural killer cells in immune surveillance of cancer. Curr Opin Immunol, 7: 704, 1995.
• 14. Soloski, M.J.: Recognition of tumor cells by the innate immune system. Curr Opin Immunol, 13: 154, 2001.
• 15. Sherman, L.A., Theobald, M., Morgan, D., Hemandez, J., Bacik, L, Yewdell, J. et al: Strategies for turnor elimination by cytotoxic T lymphocytes. Crit Rev Immunol, 18: 47, 1998.
• 16. Yung, R.L.: Changes in immune function with age. Rheum Dis Clin North Am, 26: 455, 2000.
• 17. Ginaldi, L., De Martinis, M., D’Ostilio, A., Marini, L., Loreto, M.R., Corsi, M. P. et al: The immune system in the elderly: 1. Specific humoral immunity. Immunol Res, 20: 101, 1999.
• 18. Ginaldi, L., De Martinis, M., D’Ostilio, A., Marini, L., Loreto, M.F., Martorelli, V. et al: The immune system in the elderly: 11. Specific cellular immunity. Immunol Res, 20: 109, 1999.
• 19. Ginaldi, L., De Martinis, M., D’Ostilio, A., Marini, L., Loreto, M.F. and Quaglino, D.: The immune system in the elderly: 111. Innate immunity. Immunol Res, 20: 117, 1999.
• 20. Ershler, W.B.: The influence of an aging immune system on cancer incidence and progression. J Gerontol, 48: B3, 1993.
• 21. Solana, R. and Mariani, E.: NK and NK/T cells in human senescence. Vaccine, IS: 1613, 2000.
• 22. Pawelec, G., Effros, R. B., Caruso, C., Remarque, E., Barnett, Y. and Solana, R.: T cells and aging (update February 1999). Front Biosci, 4: D216, 1999.
• 23. Pelletier, R.M. and Byers, S.W.: The blood-testis barrier and Sertoli cell junctions: structural considerations. Microse Res Tech, 20: 3, 1992.
• 24. Pelletier, R.M.: Blood barriers of the epididymis and vas deferens act asynchronously with the blood barrier of the testis in the mink (Mustela vision). Microsc Res Tech, 27: 333, 1994.
• 25. El-Alfy, M., Pelletier, G., Hermo, L.S. and Labrie, F.: Unique features of the basal cells of human prostate epithelium. Microsc Res Tech, 51: 436, 2000.
• 26. Fulmer, B.R. and Turner, T.T.: A blood-prostate barrier restricts cell and molecular movement across the rat ventral prostate epithelium. J Urol, 163. 1591, 2000.
• 27. Wright, E.T., Chmiel, J.S., Grayhack, J.T. and Schaeffer, A.J.: Prostatic fluid inflammation in prostatitis. J Urol, 152: 2300, 1994.
• 28. Streilein, J.W.: Immunologic privilege of the eye. Springer Serain Immunopathol, 21: 95, 1999.
• 29. Hickey, W.F.: Basic principles of immunological surveillance of the normal central nervous system. Glia, 36: 118, 2001.
• 30. Maddocks, S. and Setchell, B.P.: Recent evidence for immune privilege in the testis. J Reprod Immunol, IS: 9, 1990.
• 31. Ferguson, T.A. and Griffith, T.S.: A vision of cell death: insights into immune privilege. Immunol Rev, 156: 167, 1997.
• 32. O’Connell, J., Bennett, M.W., O’Sullivan, G.C., Collins, J.K. and Shanahan, F.: The Fas counterattack: cancer as a site of immune privilege. Immunol Today, 20: 46, 1999.
• 33. Apte, R. and Niederkorn, J.Y.: Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J Immunol, 156: 2667, 1996.
• 34. Green, D.R. and Ferguson, T.A.: The role of Fas ligand in immune privilege. Nat Rev Mol Cell Biol, 2: 917, 2001.
• 35. Itoh, M., Chen, X. K, Takeuchi, Y. and Miki, T.: Morphological demonstration of the immune privilege in the testis using adjuvants: tissue responses of male reproductive organs in mice injected with Bordetella pertussigens. Arch Histol Cytol, 58:575, 1995.
• 36. Ritzen, E.M.: Testicular relapse of acute lymphoblastic leukemia (ALL). J Reprod Immunol, 18: 117, 1990.
• 37. Surapaneni, U.R., Cortes, J.E., Thomas, D., O’Brien, S., Giles, F.J., Koller, C. et al: Central nervous system relapse in adults with acute lymphoblastic leukemia. Cancer, 94: 773, 2002.
• 38. Toichi, E., Hanada, K, Hosokawa, T., Higuch~ K, Hosokawa, M., linamura, S. et al: Age-related decline in humoral immunity caused by the selective loss of TH cells and decline in cellular immunity caused by the impaired migration of inflammatory cells without a loss of TDTH cells in SAMP1 mice. Mech Ageing Dev, 99: 199, 1997.
• 39. Stohlawetz, P., Kolussi, T., Jahandideh-Kazempour, S., Kudlacek, S., Graninger, W., Willvonseder, R. et al: The effect of age on the transendothelial migration of human T lymphocytes. Scand J Immunol, 44: 530, 1996.
• 40. Gittes, R.F. and McCullough, D.L.: Occult carcinoma in the prostate: an oversight of immune surveillance-a working hypothesis. J Urol, 112: 241, 1974.